ICICI Bank | Q4FY24 Result Update
Edelweiss
Fulfils expectations, plenty levers for growth
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 Apr 2024 | ICICI Bank |
Edelweiss
|
1403.80 | 1330.00 | 1160.15 (21.00%) | Target met |
Buy
|
||||
| 27 Apr 2024 | IndusInd Bank |
Edelweiss
|
755.70 | 1830.00 | 1446.40 (-47.75%) |
Buy
|
|||||
| 25 Apr 2024 | Axis Bank |
Edelweiss
|
1055.00 | 1300.00 | 1127.00 (-6.39%) | Target met |
Buy
|
||||
| 22 Apr 2024 | Elecon Engineering |
Edelweiss
|
552.00 | 1170.00 | 1155.70 (-52.24%) | Target met |
Hold
|
||||
| 19 Apr 2024 | V2 Retail |
Edelweiss
|
1666.00 | 831.00 | 491.40 (239.03%) | Target met |
Buy
|
||||
| 15 Apr 2024 | Suraj Estate |
Edelweiss
|
298.85 | 344.15 (-13.16%) |
Not Rated
|
||||||
| 29 Mar 2024 | Jeena Sikho Lifecare |
Edelweiss
|
763.80 | 841.65 (-9.25%) | Pre-Bonus/ Split |
Not Rated
|
|||||
| 28 Mar 2024 | Bharat Parenterals |
Edelweiss
|
1410.95 | 1122.20 (25.73%) |
Not Rated
|
||||||
| 28 Mar 2024 | Sanjivani paranteral |
Edelweiss
|
249.80 | 150.05 (66.48%) |
Not Rated
|
||||||
| 21 Mar 2024 | KFIN Technologies |
Edelweiss
|
1078.20 | 780.00 | 598.90 (80.03%) | Target met |
Buy
|
MF play with direct equity kicker
Edelweiss
KFin Technologies (KFINTECH) has a robust domestic MF RTA business (32% share in total MF assets) and a stable issuer charges business (45% share in market capitalisation of NSE 500 companies), and offers an optionality in international and alternatives fund administration
business. We argue the company has strong moats and shall deliver improved margins. |
|||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.